Staar Surgical (STAA) FY2018 results: revenue $124 million, up 36.8% on the year
Staar Surgical Co. (STAA) reported revenue of $124 million for fiscal 2018, the year ended 28 December 2018, up 36.8% on the year before. Net income was $5 million, and diluted earnings per share $0.11. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2019.
Revenue
$124 million
+36.8% on the year
FY2011FY2018
Operating margin
5.3%
-4.0% a year earlier
FY2011FY2018
Net income
$5 million
FY2011FY2018
Diluted EPS
$0.11
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
124
90.6
82.4
+36.8%
Cost of revenue
32.4
26.3
24.1
+23.2%
Gross profit
91.5
64.3
58.4
+42.4%
Gross margin
73.8%
70.9%
70.8%
Research and development
22.0
20.0
20.7
+9.9%
Selling, general and administrative
84.9
67.9
71.0
+25.0%
Operating income
6.6
-3.6
-12.7
Operating margin
5.3%
-4.0%
-15.4%
Interest expense
n/a
0.1
0.1
Pre-tax income
6.6
-2.3
-12.4
Income tax
1.7
-0.2
-0.3
Effective tax rate
25.2%
n/a
n/a
Net income
5.0
-2.1
-12.1
Net margin
4.0%
-2.4%
-14.7%
Diluted EPS
$0.11
-$0.05
-$0.30
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
12.8
2.9
1.0
+347.5%
Capital expenditure
2.2
1.0
3.2
+114.6%
Free cash flow
10.5
1.8
-2.2
+482.3%
Free cash flow margin
8.5%
2.0%
-2.6%
Cash from investing
-2.2
-1.0
-3.2
Cash from financing
74.6
2.4
3.0
+2,962.7%
Depreciation and amortisation
2.5
3.4
2.9
-26.5%
Share-based compensation
6.8
3.2
8.6
+113.9%
Diluted shares, weighted
45m
41m
40m
+10.4%
Shares outstanding at period end
44m
41m
41m
+6.8%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
132
42.9
37.9
+208.4%
Debt
3.8
4.4
4.3
-14.8%
Finance lease liabilities
0.5
n/a
n/a
Other liabilities
30.7
20.6
23.3
+49.2%
Total liabilities and equity
167
67.9
65.4
+146.3%
Fixed assets
11.5
9.8
11.8
+17.1%
Goodwill
1.8
1.8
1.8
0.0%
Intangible assets
0.2
0.3
0.5
-10.3%
Cash and equivalents
104
18.5
14.0
+460.9%
Receivables
25.9
17.9
16.3
+45.3%
Other assets
24.0
19.7
21.1
+21.8%
Total assets
167
67.9
65.4
+146.3%
10-K for the year ended 28 December 2018, filed 21 February 2019: the filing.